{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:43:59Z","timestamp":1772120639628,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.clinthera.2006.08.003","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T11:16:16Z","timestamp":1158664576000},"page":"1208-1216","source":"Crossref","is-referenced-by-count":82,"title":["Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 \u03bcg\/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis"],"prefix":"10.1016","volume":"28","author":[{"given":"Darego O.","family":"Maclayton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie J.","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista A.","family":"Coval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia B.","family":"York","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin W.","family":"Garey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2006.08.003_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","author":"National Nosocomial Infections Surveillance System","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.clinthera.2006.08.003_bib2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.0894-0959.2004.17339.x","article-title":"National surveillance of dialysis-associated diseases in the United States, 2001","volume":"17","author":"Tokars","year":"2004","journal-title":"Semin Dial"},{"key":"10.1016\/j.clinthera.2006.08.003_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1086\/502523","article-title":"Costs and outcomes among he modialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia","volume":"26","author":"Reed","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinthera.2006.08.003_bib4","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJMoa025025","article-title":"Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene","volume":"348","author":"Chang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2006.08.003_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2006.08.003_bib6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","article-title":"Slow response to vancomycin orvancomycin plus rifampin in meth icillin-resistant Staphylococcus aureus endocarditis","volume":"115","author":"Levine","year":"1991","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.clinthera.2006.08.003_bib7","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/j.1875-9114.1997.tb03788.x","article-title":"Retrospective evaluation of therapies for Staphylococcus aureus endocarditis","volume":"17","author":"Gentry","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2006.08.003_bib8","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/AAC.44.4.1062-1066.2000","article-title":"In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains","volume":"44","author":"Rybak","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2006.08.003_bib9","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2006.08.003_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/502550","article-title":"The case-casecontrol study design: Addressing the limitations of risk factor studies for antimicrobial resistance","volume":"26","author":"Kaye","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinthera.2006.08.003_bib11","series-title":"International Conference on Harmonisation World Health Organization. Guideline for Good Clinical Practice","author":"European Agency for the Evaluation of Medicinal Products","year":"2002"},{"key":"10.1016\/j.clinthera.2006.08.003_bib12","series-title":"Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects","author":"World Medical Association Declaration of Helsinki","year":"1989"},{"key":"10.1016\/j.clinthera.2006.08.003_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0732-8893(02)00378-4","article-title":"Validation of Vitek version 7.01 software for testing staphylococci against vancomycin","volume":"43","author":"Raney","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2006.08.003_bib14","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"10.1016\/j.clinthera.2006.08.003_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.clinthera.2006.08.003_bib16","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study","volume":"270","author":"Le Gall","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2006.08.003_bib17","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/340533","article-title":"Control-group selection importance in studies of antimicrobial resistance: Examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli","volume":"34","author":"Harris","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2006.08.003_bib18","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/jama.1976.03270150038029","article-title":"Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations","volume":"236","author":"Gopal","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2006.08.003_bib19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-115-9-739","article-title":"Staphylococcus aureus and vancomycin: The sequel","volume":"115","author":"Karchmer","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2006.08.003_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-97-4-496","article-title":"Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study","volume":"97","author":"Korzeniowski","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2006.08.003_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinids\/8.3.374","article-title":"Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: A prospective comparative study","volume":"8","author":"Levine","year":"1986","journal-title":"Rev Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2006.08.003_bib22","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/491714","article-title":"The role of vancomycin in the treatment paradigm","volume":"42","author":"Stevens","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2006.08.003_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1469-0691.2006.01344.x","article-title":"The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococ cus aureus","volume":"12","author":"Appelbaum","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2006.08.003_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/089686080302300616","article-title":"Treatment of gram positive peritonitis in peritoneal dialysis patients: Cefazolin or vancomycin?","volume":"23","author":"Levesque","year":"2003","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.clinthera.2006.08.003_bib25","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/archinte.1979.03630460058018","article-title":"Serious staphylococcal infections with strains tolerant to bactericidal antibiotics","volume":"139","author":"Denny","year":"1979","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2006.08.003_bib26","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1128\/AAC.47.12.3764-3767.2003","article-title":"Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model","volume":"47","author":"Hermsen","year":"2003","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806001834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806001834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T10:02:34Z","timestamp":1707213754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291806001834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0149291806001834"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.08.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13485032.14862159","asserted-by":"object"}]},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}